American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study

    NEXT STORY
    Global Endoscope Market is Set to Reach USD 32.8 billion by 2024, Observing a CAGR of 7.5% during 2019–2024: VynZ Research
    PREV STORY
    Histology and Cytology Market To Reach USD 30,543.4 Million By 2026 | Reports And Data
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aquinox Announces Executive Appointments

    VANCOUVER, British Columbia, May 25, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...

    author_avatar
    NASDAQ Market News

    Anchiano Therapeutics Appoints Dr. Stephen Hoffman and Robert Connelly to Its Board of Directors

    Dr. Hoffman joins the Board as Chairman Mr. Connelly is appointed as a Director ...

    author_avatar
    NASDAQ Market News

    Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News